ai in clinical trials
Dec 24, 2025
Johnson & Johnson Secures FDA Approval for TRUFILL® n-BCA in Chronic Subdural Hematoma Treatment; Abbott’s Volt™ Pulsed Field Ablation System Gains FDA Approval for AF Patients; Medicus Pharma Ltd. Partners with Reliant AI to Develop an Artificial Intelligence–Driven Clinical Data Analytics Platform; Solventum Finalized the Acquisition of Acera Surgical; Envoy Medical Hits Critical Enrollment Benchmark in Acclaim® Cochlear Implant Pivotal Trial; Galaxy Therapeutics Completes Enrollment in Pivotal SEAL IT IDE Study
Johnson & Johnson Received FDA Approval for TRUFILL n BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma On December 18, 2025, Johnson & Johnson MedTech, a leader in neurovascular care, announced that the U.S. Food and Drug Administration (FDA) had approved an expanded i...
Read More...
Oct 22, 2025
The AI Drug Discovery Revolution: Smarter Science, Faster Therapies, Better Outcomes
The pharmaceutical industry has always been a high-stakes arena, where years of research, billions of dollars, and countless clinical trials culminate in a single therapy reaching patients. Despite tremendous advancements, the traditional drug discovery process remains time-consuming, costly, and fraught with uncer...
Read More...
Oct 08, 2025
Artificial Intelligence in Clinical Trials: Transforming Drug Development Efficiency and Precision
The integration of Artificial Intelligence in clinical trials marks one of the most transformative shifts in modern drug development. As the pharmaceutical industry grapples with rising R&D costs, long trial timelines, and high attrition rates, AI in clinical trials has emerged as a catalyst for optimizing desi...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
